ClinicalTrials.gg
Enrolling by invitationNCT05112302Updated Jan 21, 2026

A Study to Evaluate Virtual Reality As Adjunct to Anesthesia During Orthopedic Surgery

An observational study in Knee Arthropathy and Hip Injuries, sponsored by Mayo Clinic. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-21.

Sponsored by Mayo Clinic · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
50
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 26 studies in Hip Injuries with a site in United States — 7 open to participants now, 10 under way, none of them phase 3. Hip Injuries · United States.

Planned enrollment
6th of 11
50 · median 50
Started
2021
with 2 others
Observational
11 of 26
5 open now
Registered
18th of 26
by date

Among the 26 studies in Hip Injuries with a site in United States, this one is the 6th largest by planned enrollment of the 11 observational ones that give a count, is one of 3 that started in 2021, is one of 11 observational ones, and was the 18th registered.

Hip Injuries

66 studies on the registry are indexed under Hip Injuries; 12 are open to participants now.

Browse Hip Injuries studies →

Open to participants now

7 of the 26 studies in Hip Injuries with a site in United States are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 8 Hip Injuries studies recruiting now, 4 set no upper age limit and 2 stop at 75 or younger; 2 take children under 18; 1 takes healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 26 studies in Hip Injuries with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to obtain feedback from patients and orthopedic surgeons who agree to use virtual reality (VR ) as an adjunct to standard of care in orthopedic cases under regional or central neuraxial nerve block. This will serve as a preliminary study for future trials to compare outcomes between VR and standard of care vs standard of care only.

03

Conditions studied

  • Knee Arthropathy
  • Hip Injuries

Browse trials for

Keywords

  • virtual reality
  • knee arthroplasty
  • hip arthroplasty
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients undergoing elective orthopedic surgery

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥ 18 years old.
  • Patients scheduled for orthopedic procedure under regional or central neuraxial nerve block (anterior primary hip arthroplasty or primary knee arthroplasty).
  • Subject willing to participate and able to provide .

Exclusion criteria

Exclusion Criteria:

  • Age \< 18 years old.
  • History of motion sickness or blindness.
  • Unable to consent due to cognitive difficulty.
  • Current diagnosis of epilepsy, dementia, or other neurological disease that may prevent use of VR hardware and software.

Sensitivity to flashing light or motion.

  • Recent stroke.
  • Injury to the eyes, face, neck, or arms that prevents comfortable use of VR hardware or software, or safe use of the hardware (e.g., open wound, sores, or skin rash on face).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
50 participants (estimated)
Patient registry
No

Groups and cohorts

  • Virtual reality

    Other: Virtual reality

Interventions

  • OtherVirtual reality

    Use of virtual reality goggles during procedure

06

What researchers measure

Primary outcomes

  1. Impact of virtual reality on anxiety level

    Evaluate patients' satisfaction with using virutal reality and reduction in anxiety during orthopedic procedures

    Time frame: Up to 2 hours

Secondary outcomes

  1. Impact of virtual reality on pharmacological therapy doses

    Elucidate the impact of VR on pharmacological therapy doses required for proper analgesia and anxiolysis and on reduction of drug side effects in patient using VR during surgeries.

    Time frame: Up to 2 hours

  2. Impact of virtual reality on patient's perioperative temperature

    Evaluate if utilizing virtual reality has a positive impact in preventing patient hypothermia intra- and post-operatively.

    Time frame: Up to 3 hours

07

Study locations

1 site
  • Mayo Clinic in Florida
    Jackson, Florida 32224, United States
08

References and documents

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Aug 2021 (actual). Primary completion is estimated for Dec 2026, 64 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 13, 2021
First posted
Nov 8, 2021
StartActual
Aug 17, 2021
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Jan 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05112302
Lead sponsor
Mayo Clinic
Responsible party
Klaus D. Torp (Principal Investigator, Mayo Clinic) — Principal investigator
First posted
Nov 8, 2021
Start date
Aug 17, 2021
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Jan 21, 2026

Study contacts

Klaus Torp, MD
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion